Cambrex Completes First Phase of $30 Million Capacity Expansion Project in High Point, North Carolina Read more
ProofPilot Announces Partnership with Human API to Advance Patient Screening and Clinical Monitoring in Research Read more
Maze Therapeutics Announces FDA Orphan Drug Designation Granted to MZE001 for the Treatment of Pompe Disease Read more
Novavax Nuvaxovid COVID-19 Vaccine Recommended by CHMP for Expanded Conditional Marketing Authorization in the European Union as a Booster for Adults Aged 18 and Older Read more
Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders Read more
Amneal Announces Submission of New Drug Application to the U.S. FDA for IPX203 for the Treatment of Parkinson’s Disease Read more
Spatial Biology CRO Flagship Biosciences Acquires Pharma Services Business from Interpace Biosciences Read more
Guardant Health Expands Strategic Collaboration With Merck KGaA, Darmstadt, Germany, to Help Accelerate Development of Precision Oncology Therapeutics Read more